These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 5378162)

  • 1. [Use of penicillin and streptomycin for the selection of auxothrophic mutants of plague microbes].
    Suchkov IuG
    Antibiotiki; 1969 Nov; 14(11):1002-6. PubMed ID: 5378162
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experimental study of the mutagenic activity of gentamicin sulfate in relation to the causative agent of plague].
    Kondrat'eva OV; Stepanov VM
    Antibiotiki; 1977 May; 22(5):447-9. PubMed ID: 879729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interrelationships of genetically-related subcultures of the causative agent of plague differing in their growth-factor requirements.
    Stepanov VM; Peisakhis LA
    Sov Genet; 1974 Feb; 7(11):1481-4. PubMed ID: 4828785
    [No Abstract]   [Full Text] [Related]  

  • 4. [Episomic resistance of Pasteurella pestis to penicillins].
    Lebedeva SA; Mishan'kin BN; Suchkov IuG
    Antibiotiki; 1972 Oct; 17(10):908-10. PubMed ID: 4572028
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of resistance selection and mutant growth fitness on the relative efficacies of streptomycin and levofloxacin for plague therapy.
    Louie A; Deziel MR; Liu W; Drusano GL
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2661-7. PubMed ID: 17517837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative evaluation of effectivity of bacteriological examination and antibody neutralization reaction during the action of streptomycin on the plague microbe.
    Aparin GP
    J Hyg Epidemiol Microbiol Immunol; 1970; 14(3):257-62. PubMed ID: 5529576
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of antibody neutralization reaction for diagnosis of plague under conditions of streptomycin therapy].
    Aparin GP
    Antibiotiki; 1970 Jul; 15(7):626-9. PubMed ID: 4920968
    [No Abstract]   [Full Text] [Related]  

  • 8. Transmission of a bacteriocinogenic factor in Pasteurella pestis.
    Kol'tsova EG; Suchkov YG; Lebedeva SA
    Sov Genet; 1971 Apr; 7(4):507-10. PubMed ID: 5163390
    [No Abstract]   [Full Text] [Related]  

  • 9. [Changes in the ultrastructure of the plague microbe in the body of guinea pigs under the influence of streptomycin].
    Kenig EE; Zhukov VG; Malinina ZE; Sageeva OF
    Antibiotiki; 1973 Jun; 18(6):546-9. PubMed ID: 4778260
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of docecyl guanidine acetate on the in vitro activity of penicillin, streptomycin, levomycetin and chlortetracycline].
    Pis'ko GT; Gudz' OV
    Antibiotiki; 1980 Feb; 25(2):107-9. PubMed ID: 7356304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Streptomycin-resistant and streptomycin-dependent variants of the causative organism of pest].
    RUBINSHTEIN PL
    Antibiotiki (Mosc); 1956; 1(2):50-3. PubMed ID: 24544058
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antibiotic effect on plague microbe antigens].
    Aparin GP
    Antibiotiki; 1973 Aug; 18(8):728-31. PubMed ID: 4776408
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of semi-synthetic penicillins on plague microbes].
    Ermol'eva ZV; Makarovskaia LN; Shcherbaniuk AI; Ved'mina EA; Kakizhanova MA; Rabinovich MS
    Antibiotiki; 1969 Dec; 14(12):1077-81. PubMed ID: 4984362
    [No Abstract]   [Full Text] [Related]  

  • 14. [The plague bacillus. I. Kinetics of growth].
    Rasolofonirina N; Coulanges P
    Arch Inst Pasteur Madagascar; 1982; 49(1):23-33. PubMed ID: 7186794
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative efficacies of candidate antibiotics against Yersinia pestis in an in vitro pharmacodynamic model.
    Louie A; Vanscoy B; Liu W; Kulawy R; Brown D; Heine HS; Drusano GL
    Antimicrob Agents Chemother; 2011 Jun; 55(6):2623-8. PubMed ID: 21486959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sensitive mutants of a penicillin-resistant Staphylococcus strain, produced by electric stimulation, Prelimininary report].
    Pelle P
    Acta Pharm Hung; 1971; 41(3):103-9. PubMed ID: 5208371
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibiotic susceptibilities of 94 isolates of Yersinia pestis to 24 antimicrobial agents.
    Hernandez E; Girardet M; Ramisse F; Vidal D; Cavallo JD
    J Antimicrob Chemother; 2003 Dec; 52(6):1029-31. PubMed ID: 14613959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transformation of the agent of plague into the L-form].
    Stepanov VM; Kondrat'eva OV; Temiralieva GA; Arakelian IS; Uzbekov BK
    Zh Mikrobiol Epidemiol Immunobiol; 1980 May; (5):58-60. PubMed ID: 7415679
    [No Abstract]   [Full Text] [Related]  

  • 19. Bacterial filamentation of Yersinia pestis by beta-lactam antibiotics in experimentally infected mice.
    Davis KJ; Vogel P; Fritz DL; Steele KE; Pitt ML; Welkos SL; Friedlander AM; Byrne WR
    Arch Pathol Lab Med; 1997 Aug; 121(8):865-8. PubMed ID: 9278616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antibiotic sensitivity of strains of the plague microbe isolated from foci in the Caucasus and Transcaucasia].
    Tarasova VE; Eremitskaia GN; Proskurina VA
    Antibiotiki; 1981 May; 26(5):365-7. PubMed ID: 7259143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.